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Abstract
Present study was conducted to evaluate the preliminary phytochemical screening and hepatoprotective activity of whole plant of
Evolvulus alsinoides. The whole plant was defatted with petroleum ether and then extracted with 90 % ethanol. The phytochemi-
cal screening was done for ethanol extract using standard procedures. Acute toxicity was done using OECD 423 guidelines and
the extract was found to be practically non-toxic upto a dose of 1500mg/kg b.w. when given orally. Hepatoprotective activity was
evaluated using Carbon tetra chloride induced model in rats. In CCl4 induced mothod of 90% Ethanolic extract of whole plant
of Evolvulus alsinoides (75 & 150mg/kg b.w.) produced significant dose dependent hepatoprotective acti vity. Histopathological
studies could be carried out to assess the degree of damage. The hepatoprotective effect of the aforesaid extract was substan-
tiated by pentobarbital sleeping time experiment in mice. The effect of the extracts at 150 mg/kg was compared to that of the
reference drug, Silymarin (50 mg/kg). In vitro antioxidant studies were conducted to confirm the antioxidant mechanism involved
in their hepatoprotective activity in CCl4 -induced in rats. The presence of flavonoids could be responsible for hepatoprotective
activity.
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Introduction
Hepatotoxicity is defined as injury to the liver that is associated
with impaired liver function caused by exposure to a drug or
another non-infectious agent. Hepatotoxic agents can react with
the basic cellular components and consequently induce almost
all types of liver lesions. Toxins and drugs are among the basic
etiopathogenetic agents of acute liver failure in Western coun-
tries. Nevertheless, chemical toxins (including acetaminophen,
carbon tetrachloride, galactosamine and thioacetamide) are often
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used as the model substances causing experimental hepatocyte
injury in both in vivo and in vitro conditions. Despite the fact
that hepatic problems are responsible for a significant number of
liver transplantations and deaths recorded worldwide, available
pharmacotherapeutic options for liver diseases are very limited
and there is a great demand for the development of new effective
drugs [1].
Herbal-based therapeutics for liver disorders has been in use
in India for a long time and has been popularized world over
by leading pharmaceuticals. Despite the significant popularity of
several herbal medicines in general, and for liver diseases in par-
ticular, they are still unacceptable treatment modalities for liver
diseases. The use of natural remedies for the treatment of liver
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diseases has a long history, starting with the Ayurvedic treat-
ment, and extending to the Chinese, European and other systems
of traditional medicines [2].
The curative properties of medicinal plants are mainly due to
the presence of various complex chemical substances of different
composition, which occur as secondary metabolites. They are
grouped as alkaloids, glycosides, flavonoids, saponins, tannins;
carbohydrates & essential oils. Any part of the plant may contain
active components. The medicinal action of plants are unique to
particular plant species or groups of plants and are consistent
with this concept as the combination of secondary products in a
particular plant is taxonomically distinct [3].
Abundant natural substances, inorganic chemicals which are
absorbed through intestinal tract, nasal route or by parenteral
route are metabolized by liver. Cytochrome P450 reductase en-
zyme system which is present in the smooth endoplasmic retic-
ulum of liver facilitates the metabolism of diverse substances.
Over dosage or excess use of the drugs, chemical agents, micro-
cystins etc generally referred as hepatotoxins which cause hep-
atotoxicity. Hepatotoxicity is the main reason for most of the
drugs to be withdrawn from market [4]. Some of the pharmaceu-
tical, chemical products and the waste materials are hepatotoxins
which enter into the human body. One of the potent hepatotoxic
agents is CCl4, when it is ingested it gets circulated to all organs
because of its high lipid solubility. On ingestion of toxic doses
it causes blockage in the lipoprotein synthesis and produces fat
accumulation in the liver because these lipoproteins carry the
triglycerides away from this organ. The synthesis of proteins is
reduced and there is a rapid decline in the levels of cytochrome
P450 as well as glucose 6-phosphatase and the sequestration of
Ca2+ ions by Ca2+ ATPase is reduced by the endoplasmic retic-
ulum, as a result there is an increased intracellular Ca2+ concen-
tration [5].
A number of studies have shown that the plant extracts hav-
ing antioxidant activity protect against CCl4 hepatotoxicity by
inhibiting lipid peroxidation and enhancing antioxidant enzyme
activity [1].
Evolvulus alsinoides (Family Convolvulaceae ) is a herb
from Ayurveda for the treatment of fever, cough, and cold as
well as for venereal diseases, azoospermia, asthma and bron-
chitis [6, 7], adenitis and dementia and liver problems [8, 9].
This plant is reported to have a nootropic and psychotropic ef-
fect [10], topical application is said to promote hair growth, and
is also referred to as Drawf morning glory. It is used commonly
in modern days to promote vitality and memory similar to Ash-
wagandha, Bacopa monnieri, and Jatamansi [10] and is reported
to be somewhat tasteless. However, there is no scientific report
or verification of the use of this plant in the treatment of these
conditions. Evolvulus alsinoides (EEEA) has been initiated in
our laboratory and here we report the preliminary result of stud-




The whole plants of Evolvulus alsinoides were collected in Tiru-
pathi, Andhra Pradesh, India, and authenticated by the renowed
botanist from the Department of Botany, Sri Venkateswara Uni-
versity, Tirupati, Andhra Pradesh, India. A voucher specimen
(No. SHM 01/12) has been preserved in our laboratory for fu-
ture reference. The plant material were dried under shade and
then powdered with a mechanical grinder and stored in airtight
container. The dried powder material of the whole plant was
defatted with petroleum ether and the marc thus obtained was
then extracted with ethanol in a soxhlet apparatus. The solvent
was completely removed under reduced pressure and a semisolid
mass was obtained ( EEEA, yield 15.67 %). The dried EEEA
was suspended in normal saline and used for the present study.
Phytochemical Analysis
The crude ethanolic extract of herbal plant was subjected to
the following chemical tests for the identification of various ac-
tive constituents like alkaloids, carbohydrates, steroids, glyco-
sides, saponins, flavonoids, tannins, phenolic compounds, triter-
penoids, proteins, aminoacids and fixed oils [11–16].
Chemicals
Silymarin was used as a standard hepatoprotective agent and
was obtained as a kind gift from Micro Labs., Ltd., Hosur
(Bangalore), India; Methanol, Carbon tetrachloride, Ethanol,
Ferric chloride, Ferrozine, Tween-80 were obtained from
S.D Fine Chemicals, Mumbai; Olive oil is obtained from
Seven Ships, Hyderabad and Normal Phase Pre-coated Chro-
matographic Plates were purchased from Merck, Germany.
Analytical kits Serum Glutamic Oxaloacetate Transaminase
(SGPT), Serum Glutamic Pyruvic Transaminase (SGOT), Alka-
line phosphate (ALP) Total Bilirubin (TBL), Total protein (TPL)
and Albumin (ALB) by manual methods were purchased from
Span, Diagnostics Ltd., Surat, India. The biochemical analytical
kits for colorimeter were purchased from Merck Specialties Pri-
vate Limited, Mumbai, India. All other chemicals and solvents
used were of analytical grade.
Experimental animals
Healthy Wistar A lbino rats, weighing 200-220g were procured
from the Teena Biolabs Pvt. Ltd. (Reg, no. 177/99 CPCSEA),
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Hyderabad, Andhra pradesh. Animals were housed at CPCSEA
approved animal house of Vaagdevi Institute o f Pharmaceuti-
cal Sciences, (1533/PO/a/11/CPCSEA) Warangal. The animals
were kept under standard laboratory condition (12 hr light and
12 hr dark cycle) and had free access to commercial pellet diet
(Vyas labs Ltd, Hyderabad, India) with water ad libitum.The ani-
mal house temperature was maintained at 25± 20 C with relative
humidity at (50 ±15%). The study was approved by the Institu-
tional Animal Ethical Committee of Vaagdevi Institute of Phar-
maceutical Sciences, (14/03/2012). Ethical norms were strictly
followed during all experimental procedure.
Acute Oral Toxicity Study
The acute oral toxicity procedure was followed by using OECD
423 guidelines. The acute toxic class method is a stepwise pro-
cedure with 6 animals of a single sex per step [17]. The different
doses of EEEA ( 5, 50, 300, 2000 mg/kg body weight) were ad-
ministered orally to the rats. After the oral administration of test,
animals were observed individually at least once during the first
30 minutes and periodically during the first 24 hours, with spe-
cial attention given during the first 4 hours and daily thereafter,
for total of 14 days.
Hepatoprotective Activity: In the present study, all animals
were kept on same diet for 7 days. Seven days after acclima-
tization, the rats were divided into five groups, each group con-
sisting of six animals. Group-I served as a control and received
1ml/kg of 1 %w/v tween-80 in distilled water p.o. for seven days.
Group-II t reated with vehicle (1 ml/kg of 1% w/v tween-80 in
distilled water p.o.) daily for seven days followed by CCl4 on the
seventh day. The Group-III animals were administered with 50
mg/kg of standard drug Silymarin p.o. for seven days followed
by CCl4 administration. Group IV- V test groups were treated in
the similar way using ethanolic extract of Evolvulus alsinoides
(EEEA) 75, 150 mg/kg, respectively followed by CCl4 adminis-
tered p.o on the seventh day [18].
All the rats were anaesthetized with thiopental sodium (60
mg/kg intraperitoneally), 36 hrs after administration of
CCl4,blood was collected from the retro-orbital plexus of rats,
by inserting a fine capillary gently in the inner angle of the eye.
The capillary is slided under the eye ball at 450 angle and over
the bone socket to rupture the fragile venous capillaries of the
ophthalmic venous plexus. The passage is about 10 mm. The tip
of the capillary is slightly retracted and the blood was collected
in a tube from orbital cavity with the capillary. After collecting
the desired volume, capillary is removed with simultaneous re-
lease of pressure by fore finger and thumb. Any residual blood
droplet around the eyeball is wiped off by dry cotton wool. After
blood collection, the blood samples were allowed to coagulate
at room temperature for at least one hour. Serum was separated
by centrifugation at 3000 rpm for 30 minutes and then analyzed
for TB, SGPT, SGOT, ALP, TP and ALB levels [19–22]. The
animals were then dissected, the livers were carefully removed,
washed with 0.9% saline solution and preserved in formalin
solution (10% formaldehyde) for histopathological studies.
Determination of sleeping time: Pentobarbitone-induced
sleeping time was carried out in Swiss albino mice. A 50%
v/v CCl4 in olive oil at a dose of 1.5 ml/kg/p.o was used as the
toxic substance for inducing liver damage.
Group-I served as a control and received 1 ml/kg of 1%
TWEEN-80 in distilled water p.o. for seven days. Group-II
served as a toxic control and were given 1% TWEEN-80 for
seven days followed by 1.5 ml/kg of CCl4 (50% v/v CCl4 in
olive oil) only on the 7th day p.o. The Group-III (Standard) an-
imals were administered with 50 mg/kg of Silymarin p.o. for
seven days followed by 1.5 ml/kg of CCl4 (50% v/v CCl4 in
olive oil) only on the 7th day p.o. Groups IV, V were treated in
the similar way to that of Group III (Standard) using ethanolic
extract of Evolvulus alsinoides (EEEA) 75 mg/kg, 150 mg/kg a
respectively.
All the various groups of animals were given Pentobarbitone
60 mg/kg i. p. 2 hrs after administration of CCl4. The time be-
tween loss of righting reflex and its recovery was recorded [23].
Histopathological Studies: After the animals were sacrificed,
livers were taken out and washed with normal saline (0.9%).
Then, 2-3 pieces of approximately 6 mm3 size were cut and
fixed in phosphate buffered 10% formaldehyde solution. After
embedding in paraffin wax, thin sections of 5 mm thickness of
liver tissue were cut and stained with haemotoxylin-eosin stain.
In-vitro antioxidant studies:
DPPH Free Radical Scavenging Assay: The antioxidant ac-
tivity was determined on the basis of a free radical scaveng-
ing activity of stable 1,1-Di Phenyl-1, 2-picryl hydrazyl (DPPH)
radical. 0.5 ml of the different concentrations of the extract was
mixed with 2 ml of DPPH solution, 0.5 ml of TRIS Buffer and
2 ml of methanol. Ascorbic acid was used as a standard and pre-
pared in a manner similar to the test. All the samples were mixed
thouroughly and allowed to stand in a dark for 30 min. T he ab-
sorbance was measures at 517 nm using methanol as a blank.
All determinations were made in triplicate and t he percentage
inhibition was calculated using the following formula [24] .
% Inhibition = (Control – Test)/ Control X 100
Metal chelating activity: The chelation of ferrous ions by
extracts was estimated by method of Dinis et al., 1994 [25].
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Briefly, 50 µl of 2 mM FeCl2 was added to 1 ml of different
concentrations of the extract (0.2, 0.4, 0.8, 1.6 and 3.2 mg/ml).
The reaction was initiated by the addition of 0.2 ml of 5 mM
ferrozine solution. The mixture was vigorously shaken and left
to stand at room temperature for 10 min. The absorbance of
the solution was thereafter measured at 562 nm. All determi-
nations were made in triplicate and t he percentage inhibition
of ferrozine–Fe2+ complex formation was calculated using the
formula
% Activity = [(A0- As)/ As] X100
where A0 was the absorbance of the control, and As was the
absorbance of the extract/ standard. Na2 EDTA was used as pos-
itive control.
Results and discussion
Powder of dried whole plant Evolvulus alsinoides was extracted
and a total of 70gm of extract having black color was obtained.
The percentage yield of the plant was found to be 15.67%.
The phytochemical investigation of the crude extract revealed
the presence of flavonoids, carbohydrates, triterpenoides, glyco-
sides, proteins, alkaloids, amino acids, tannins and phenolics and
absence of fixed oils and saponins.
Acute toxicity
The ethanolic extract of whole plant of Evolvulus alsinoides was
found to be safe at the maximum tested dose of 1500mg/kg body
weight by oral route. After 24 hours animals was found well tol-
erated. There was no mortality and no signs of toxicity. A gen-
eral behavioural, neurological and autonomic profile was found
to be normal and all the concentrations of extracts were found
to be safe. Thus 1/10th of the maximum tolerated dose i.e; 150
mg/kg was taken as effective dose. The study was conducted us-
ing two doses i.e; 75mg/kg b.w p.o. and 150mg/kg b.w p.o.
Hepatoprotective activity
In recent years, many studies have been undertaken with indige-
nous medicinal plants in an attempt to develop safe and effective
herbal drug for the treatment of liver disorders. In the present
study, the mechanistically hepatoprotective model viz. CCl4,
was used for liver damage induction, to investigate whether the
selected plant extract could decrease efficiently the toxicity pro-
duced by the hepatotoxicants.
The results of the present study demonstrate that the various
biochemical changes produced in serum as well as liver and his-
tological changes of liver by CCl4 toxicity were prevented or
reversed by administration of EEEA (Table 1).
The CCl4 administration to rats leads to marked elevation in
the levels of serum ALT, AST and ALP. This might be due to the
release of these enzymes from the cytoplasm of hepatic cells,
into the blood circulation rapidly after rupture of the plasma
membrane and cellular damage [26], resulting from the CCl4
-induced lipid peroxidation [27]. Treatment with EEEA at 75
and 150 mg/kg b.w.p.o. significantly reduced the level of these
marker enzymes in CCl4 treated rats in hepatoprotective study.
The decrease in the levels of these enzymes may be a conse-
quence of the stabilization of plasma membrane as well as repair
of hepatic tissue damage caused by CCl4 (Table 1) [28].
In CCl4 induced hepatotoxicity, elevated serum TB level is
due to defective excretion of bile by the liver indicates the loss
of integrity of the liver and necrosis. This leads to increase in
the binding, conjugating and excretory capacity of hepatocytes,
which is proportional to the erythrocyte degeneration rate [29].
At both the test doses EEEA showed a significant depletion in
the serum bilirubin level suggesting the possibility of the extracts
ability to stabilize biliary dysfunction of rat liver during injury
with CCl4 in prophylactic and curative studies.
In CCl4 hepatotoxicity, a depression in total protein oc-
curs due to the disruption and dissociation of polyribosome on
endoplasmic reticulum leading to defective protein biosynthe-
sis [30, 31]. In hepatoprotective study, EEEA at 75 and 150
mg/kg doses, increased the serum TP and ALB levels with vary-
ing degree of significance. This may be due to the promotion of
the assembly of ribosomes on endoplasmic reticulum to facili-
tate uninterrupted protein biosynthesis. The overall observation
made on the biochemical parameters revealed that the extract
have better hepatoprotective activity with the higher dose i.e.
150 mg/kg b.w.p.o., comparable to that of the reference drug,
Silymarin (50 mg/kg).
The histopathological profile of the liver of CCl4 adminis-
tered rats revealed drastic alterations in histoarchitecture show-
ing centrilobular necrosis, fatty changes, broad infiltration of
lymphocytes and vacuolization. In hepatoprotective studies;
EEEA at both test doses showed definite signs of protection
and recovery against CCl4 injury respectively. The effects of the
extracts were proportionate with the doses.
The liver is made up of hepatocytes and specialized cells
called Kupffer cells interspersed with sinusoids. It is supplied
with branches of bile duct. The normal hepatocytes have intact
plasma membrane while in the event of viral infection/disease
state or when drugs or chemicals affect liver cells, there will be
changes in the permeability of plasma membrane and disruption
of cells is caused by excessive formation of fibrotic tissue even-
tually leading to necrosis.
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Table 1 Hepatoprotective activity of ethanolic extract leavesof EvolvulusAlsinoides (EEEA) on different biochemical parameters in CCl4 induced liver
damage in rats.
Groups SGPT (U/ml) SGOT (U/ml) ALP (U/L) TB (mg/dL) TP (gm/dL) ALB (gm/dL) CHOL (mg/dL)
Normal 43.25±5.46 48.6±3.61 18.66±1.51 2.41±1.06 8.75±0.29 2.58±0.22 79.3±4.87
Toxic Control (CCl4
)
152.4±12.31 131.7±12.76 78.59±8.15 7.25±0.37 2.55±0.14 1.11±0.06 148.3±3.19
Standard
(Silymarin)
69.75±3.39∗∗∗ 75.23±5.09∗∗∗ 43.08±2.41∗∗∗ 2.75±0.29∗∗∗ 7.09±0.09∗∗∗ 2.45±0.19∗∗∗ 99.74±2.39∗∗∗
EEEA 75 107.8±10.56∗∗ 107.9±12.7 60.31±4.52∗ 5.09±0.05∗ 3.92±0.44∗ 1.7±0.05∗ 132.9±3.07∗
EEEA 150 87.07±5.84∗∗∗ 85.20±5.57∗∗∗ 50.99±3.81∗∗∗ 3.63±0.26∗∗∗ 5.95±0.4∗∗∗ 2.2±0.11∗∗∗ 108.4±3.999∗∗∗
V alues expressed as Mean ± SEM (n=6). Significant*(P <0.05), ** (P<0.01), *** (P<0.001) compared with standard and toxic group.
Histopathological studies could be carried out to assess the
degree of damage. This is done by staining the fine section
of liver isolates and examining under the microscope.It is evi-
dent from the results that the biochemical and histopathologi-
cal observations of the studies were complementing each other.
This confirms that ethanolic extract of whole plant E. alsinoides
(EEEA), have hepatoprotective effect in CCl4− induced hepato-
toxicity in rats by their ability to stabilize cell membranes, scav-
enge free radicals and antioxidant properties.
The hepatoprotective effect of the aforesaid extracts was sub-
stantiated by pentobarbital sleeping time experiment in mice.
The duration of pentobarbital-induced sleep in intact animals is
considered as a reliable index for the activity of hepatic micro-
somal drug metabolizing enzymes (MDME) [32]. The pentobar-
bital is metabolized by hepatic MDME to inactive metabolites
and any drug with an inhibitory effect on MDME is expected
to prolong pentobarbital-induced sleep time. The damage con-
ferred by CCl4 on hepatocytes as well as on the hepatic MDME
causes a loss of drug metabolizing capacity of the liver, resulting
in prolongation of pentobarbital induced sleep time [33]. This in-
dicates the hepatoprotective potential of the test extracts against
CCl4 -induced damage to hepatocytes including MDME. The
effect of the extracts at 150 mg/kg was compared to that of the
reference drug, Silymarin (50 mg/kg) (Table 2).
Table 2 Effect of EEEA on pentobarbitone induced sleeping time in
CCl4 intoxicated rats
Group Dose (mg/kg) Sleeping time in min
Normal .. 61.33
Toxic control (CCl4 ) .. 136.59
Standard (Silymarin) 50 78.18
EEEA 75 75 91.73
EEEA 150 150 88.68
In vitro antioxidant studies were conducted to confirm the
antioxidant mechanism involved in their hepatoprotective activ-
ity in CCl4 -induced in rats. It has been shown that protective
agents exert their action against CCl4 -induced liver injury by
impairment of CCl4 mediated lipid peroxidation, either through
decreased production of free radical derivatives [34] or due to
the antioxidant activity of the protective agent itself [35] . In
DPPH method, test extract exhibited a concentration dependent
DPPH radical scavenging activity. The maximal activity was
found at the highest concentration used i.e., 1000 µg/ml. In vitro
ion chelating study also supported the free radical scavenging ac-
tivity of the test extract. It exhibited a concentration dependent
protection against ion chelation as evident from the ameliorated
MDA levels in liver microsomes. The results suggest that the
hepatoprotective activity of the ethanolic extract may be due to
the inhibition of the ion chelation resulting in the enhancement
of the resistance of the hepatocyte membrane to CCl4 -mediated
injury. Hence, the bioactive compounds (EEEA) were found to
possess antioxidant properties. The results of the study substan-
tiate the role of antioxidant properties of the ethanolic extract in
showing their hepatoprotective effect in CCl4 -induced hepato-
toxicity in rats (Table 3 and 4).
Table 3 DPPH radical scavenging activity of EEEA








Ascorbic acid (25µg) 84.56
Table 4 Metal chelating activity of EEEA







Na2 EDTA (50µg) 79.27
It is well known that plants or their extracts contain a num-
ber of chemicals belonging to the different classes, most of them
are of pharmacological importance such as flavonoids, steroids,
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triterpenoids and their glycosides, etc. Hence, the extract was
subjected to preliminary chemical analysis to identify the classes
of compounds present in them. The results of the study re-
vealed the presence of carbohydrates, flavonoidal glycosides and
steroidal/triterpenoidal compounds in the compound (EEEA). It
is well documented that flavonoids are strong antioxidants and
posses hepatoprotective activity, eg. quercetin, ascorbic acid and
rutin [36]. Further, the literature reveals that the plants contain-
ing steroids and triterpenoids can control liver diseases [37].
Therefore, the hepatoprotective activity of the bioactive extract
may be attributed to the above classes of compounds present in
the respective bioactive extract.
From the overall results, it can be concluded that the indige-
nous medicinal plant selected for the investigation viz. Evolvu-
lus alsinoides possess hepatoprotective activity. The ethanolic
extract of this plant (EEEA) exhibited hepatoprotective activity
against CCl4 induced liver injury in rats. The mechanism of ac-
tion behind the hepatoprotective activity of the aforesaid extracts
may be multifactorial. It could be due to; (1) prevention of the
process of lipid peroxidation through free radical scavenging,
(2) stabilization of the hepatocellular membrane, (3) prevention
of inflammation, (4) inhibition of cytochrome P-450 activity and
(5) enhancement of protein biosynthesis. However, comprehen-
sive investigations are required to elucidate the exact mechanism
of action, to evaluate its efficacy and toxicity in other models,
and to carry out pre-formulation studies for developing it as a
safe and effective herbal protectant.
Conclusion
Present study reveals the hepatoprotective activity of 90%
ethanolic extract of whole plant of Evolvulus alsinoides on
Carbon tetrachloride induced model. The extract was found
to be practically non-toxic upto a dose of 1500mg/kg b.w.
when given orally. In CCl4 induced method the extract (75 &
150mg/kg b.w.) produced significant dose dependent hepatopro-
tective activity. T he presence of flavonoids could be responsible
for hepatoprotective activity, is more likely to be involved in
the reaction with the proteins of the layer tissues and thereby
showing the activity.
Having confirmed the hepatoprotective activity of Evolvulus
alsinoides on liver , it deserves further studies to identify which
exact chemical constituents of the ethanolic extract mediated
the specific observed effects and investigate their mechanism,
as also the isolation and characterization of active principles re-
sponsible for hepatoprotective activity.
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